Managing Blood Pressure in the Elderly: What Is Different?

  • Sergio F. F. Santos
  • George Sunny Pazhayattil
  • Aldo J. Peixoto


Blood pressure (BP) management is essential in patients with end-stage kidney disease (ESKD) on maintenance dialysis as hypertension is the most common cardiovascular risk factor in this population. Even though this is true across all age groups, the aging process adds challenges to the evaluation and management of BP in dialysis patients. In this chapter, we will review aspects related to the management of BP and the treatment of hypertension in patients on chronic maintenance dialysis, with a focus on issues that are modified by the aging process, being mindful of the caveat that data restricted to elderly patients are scanty.


Blood pressure measurement Blood pressure monitoring Hypertension Intradialytic hypertension Intradialytic hypotension Anti-hypertensive drugs 


  1. 1.
    Agarwal R (2012) The controversies of diagnosing and treating hypertension among hemodialysis patients. Semin Dial 25:370–376CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Ortega LM, Materson BJ (2011) Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment. J Am Soc Hypertens 5:128–136CrossRefPubMedGoogle Scholar
  3. 3.
    Myers OB, Adams C, Rohrscheib MR et al (2010) Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol 21:1970–1978CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Peixoto AJ, Santos SF (2010) Blood pressure management in hemodialysis: what have we learned? Curr Opin Nephrol Hypertens 19:561–566CrossRefPubMedGoogle Scholar
  5. 5.
    Zoccali C (2003) Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 18:249–252CrossRefPubMedGoogle Scholar
  6. 6.
    Agarwal R, Sinha AD (2009) Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension 53:860–866CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw ZD, Grobbee DE, Jardine MJ, Gallagher M, Roberts MA, Cass A, Neal B, Perkovic V (2009) Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet 373:1009–1015CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Laegreid I, Bye A, Asarod K, Jordhoy M (2012) Nutritional problems, overhydration and the association with quality of life in elderly dialysis patients. Int Urol Nephrol 44:1185–1192CrossRefGoogle Scholar
  9. 9.
    Agarwal R, Alborzi P, Satyan S, Light RP (2009) Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 53:500–507CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Santos SF, Peixoto AJ, Perazella MA (2012) How should we manage adverse intradialytic blood pressure changes? Adv Chronic Kidney Dis 19:158–165CrossRefPubMedGoogle Scholar
  11. 11.
    Briet M, Boutouyrie P, Laurent S, London GM (2012) Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int 82:388–400CrossRefPubMedGoogle Scholar
  12. 12.
    Sankaranarayanan N, Santos SFF, Peixoto AJ (2004) Blood pressure measurement in dialysis patients. Adv Chron Kidney Dis 11:134–142CrossRefGoogle Scholar
  13. 13.
    Pickering TG, Hall JE, Appel LJ et al (2005) Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the american heart association council on high blood pressure research. Hypertension 45:142–161CrossRefPubMedGoogle Scholar
  14. 14.
    Reddy AK, Jogendra M, Rosendorff C (2014) Blood pressure measurement in the geriatric population. Blood Press Monit 19:59–63CrossRefPubMedGoogle Scholar
  15. 15.
    K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients (2005) Blood pressure. Am J Kidney Dis 45(Suppl 3):S49–S57Google Scholar
  16. 16.
    Agarwal R, Lewis R (2001) Prediction of hypertension in chronic hemodialysis patients. Kidney Int 60:1982–1989CrossRefPubMedGoogle Scholar
  17. 17.
    James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA 311:507–520CrossRefPubMedGoogle Scholar
  18. 18.
    Aronow WS, Fleg JL, Pepine CJ, Artinian NT et al (2011) ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus. J Am Soc Hypertens 5:259–352CrossRefPubMedGoogle Scholar
  19. 19.
    Santos SFF, Peixoto AJ (2010) Sodium balance in maintenance hemodialysis. Semin Dial 23:549–555CrossRefPubMedGoogle Scholar
  20. 20.
    Santos SF, Peixoto AJ (2008) Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients. Clin J Am Soc Nephrol 3:522–530CrossRefPubMedGoogle Scholar
  21. 21.
    Hecking M, Karaboyas A, Saran R et al (2012) Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization and mortality. Clin J Am Soc Nephrol 7:92–100CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Dou Y, Zhu F, Kotanko P (2012) Assessment of extracellular fluid volume and fluid status in hemodialysis patients: current status and technical advances. Semin Dial 25:377–387CrossRefPubMedGoogle Scholar
  23. 23.
    Levin NW, Kotanko P, Eckardt KU, Kasiske BL, Chazot C, Cheung AK, Redon J, Wheeler DC, Zoccali C, London GM (2010) Blood pressure in chronic kidney disease stage 5D-report from a kidney disease: improving global outcomes controversies conference. Kidney Int 77:273–284CrossRefPubMedGoogle Scholar
  24. 24.
    Sinha AD, Light LP, Agarwal R (2010) Relative plasma volume monitoring during hemodialysis aids the assessment of dry weight. Hypertension 55:305–311CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Matsumoto Y, Mori Y, Kageyama S et al (2014) Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients. J Am Coll Cardiol 63:528–536CrossRefPubMedGoogle Scholar
  26. 26.
    Ito Y, Mizuno M, Suzuki Y et al (2014) Long term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol 25:1094–1102CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Inrig JK, Van Buren P, Kim C, Vongpatanasin W, Povsic TJ, Toto R (2012) Probing the mechanisms of intradialytic hypertension: a pilot study targeting endothelial cell dysfunction. Clin J Am Soc Nephrol 7:1300–1309CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Sergio F. F. Santos
    • 1
  • George Sunny Pazhayattil
    • 2
  • Aldo J. Peixoto
    • 2
  1. 1.Division of NephrologyState University of Rio de JaneiroRio de JaneiroBrazil
  2. 2.Section of NephrologyYale University School of MedicineNew HavenUSA

Personalised recommendations